HY-P1159A-10mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
HY-P1159A-5mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
HY-120833-1mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
HY-120833-10mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
HY-120833-25mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
HY-120833-5mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
HY-P0262-1mg
|
MedChemexpress LLC
|
Galantide [CAS 138579-66-5]
|
|
COVID-19-immunoregulation
|
|
HY-P0262-5mg
|
MedChemexpress LLC
|
Galantide [CAS 138579-66-5]
|
|
COVID-19-immunoregulation
|
|
HY-P0262-500ug
|
MedChemexpress LLC
|
Galantide [CAS 138579-66-5]
|
|
COVID-19-immunoregulation
|
|
HY-P99263-1mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99263-10mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99263-5mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-108483-10mg
|
MedChemexpress LLC
|
RP 67580 [CAS 135911-02-3]
|
|
|
|
HY-108483-5mg
|
MedChemexpress LLC
|
RP 67580 [CAS 135911-02-3]
|
|
|
|
AAP57712
|
Aviva Systems Biology
|
MYL6 [Middle], Blocking Peptide
|
|
IHC, WB
|
|
AAP57711
|
Aviva Systems Biology
|
MYL6 [N-term], Blocking Peptide
|
|
IHC, WB
|
|